Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

Overview of attention for article published in BMC Neurology, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 1 blog

patent: 7 patents

Citations

dimensions_citation: 147 Dimensions

Readers on

mendeley: 177 Mendeley
citeulike: 1 CiteULike

Summary Blogs Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

METHODS, SYSTEMS, AND KITS FOR PREDICTION, DETECTION, MONITORING, AND TREATMENT OF…

Application WO-2022093274-A1

World Intellectual Property Organisation (WIPO)

MELANOTRANSFERRIN FOR USE IN THE DIAGNOSIS OF PARKINSON`S DISEASE

Application WO-2018060003-A1

World Intellectual Property Organisation (WIPO)

MELANOTRANSFERRIN FOR USE IN THE DIAGNOSIS OF PARKINSON'S DISEASE

Application EP-3301113-A1

European Patent Office

SALIVARY ABETA42 LEVELS AS PROGNOSTIC INDICATORS FOR ALZHEIMER'S DISEASE

Application WO-2018018138-A1

World Intellectual Property Organisation (WIPO)

SPECIFIC SALIVARY BIOMARKERS FOR RISK DETECTION, EARLY DIAGNOSIS, PROGNOSIS AND…

Application EP-3255435-A1

European Patent Office

LACTOFERRIN FOR USE IN THE DIAGNOSIS OR PROGNOSIS OF ALZHEIMER'S DISEASE

Application EP-3171174-A1

European Patent Office

SPECIFIC SALIVARY BIOMARKERS FOR RISK DETECTION, EARLY DIAGNOSIS, PROGNOSIS AND…

Application WO-2013153461-A3

World Intellectual Property Organisation (WIPO)